Symbiose Innovation is dedicated to accelerating the translation of knowledge from the fundamental to the practical and to the community. To achieve this, we apply the principles of translational research to create winning conditions where all players in the research continuum (patients, clinicians, researchers, managers, decision-makers) can collaborate and contribute to the collective intelligence to improve the care of citizens living with rare diseases.
Réseaux sociaux
Domaines d'activité
Technologies de bioproduction et de médecine régénérative
1. HORIZON HLTH 2027 03 TOOL 02 – Advancing bioprinting of living cells for regenerative medicine2. HORIZON HLTH 2027 01 IND 01 – Cell free protein synthesis platforms for discovery/production of biologicals4. HORIZON HLTH 2027 02 DISEASE 14 two stage – Clinical trials for innovative interventions in neurodegenerative diseases5. HORIZON MISS 2027 02 CANCER 03 – First in human clinical trials for rare or very rare cancers
Technologies de santé numérique, intelligence artificielle et soins de santé axés sur les données
1. HORIZON HLTH 2027 03 TOOL 04 – Virtual Human Twins (VHTs) for integrated clinical decision support2. HORIZON HLTH 2027 03 TOOL 08 – Towards Artificial General Intelligence (AGI) for healthcare
Médecine de précision et personnalisée
2. HORIZON HLTH 2027 02 DISEASE 01 two stage – Innovative healthcare interventions for non communicable diseases4. HORIZON MISS 2027 02 CANCER 01 – Functional genomics to reveal novel targets for cancer treatment5. HORIZON MISS 2027 02 CANCER 02 – Clinical research by Comprehensive Cancer Infrastructures
Symbiose Innovation supports the structuring, implementation and coordination of international health collaborations, connecting scientific, clinical, patient and industry expertise to advance translational research.
Symbiose Innovation is looking to collaborate with research, clinical, patient, industry and innovation stakeholders to structure, implement and coordinate multidisciplinary projects in rare diseases and rare cancers.
Symbiose Innovation is seeking partnerships with organisations active in rare diseases and rare cancers to develop joint initiatives, connect complementary expertise and strengthen international collaboration across research and innovation ecosystems.